Partnered Drug Discovery Services

About Stem Pharm

Founded in 2013, Stem Pharm has developed a dual-platform business focused on synthetic biomaterials and advanced human neural organoids, particularly those featuring microglia for neuroinflammatory modeling. The company operates as a private, revenue-generating CRO/platform provider, partnering with biopharma companies on neurologic drug discovery programs. Its recent recognition through a state commercialization award and published validation studies highlight the growing traction of its technology in modeling complex diseases like Alzheimer's and reducing reliance on animal testing.

Therapeutic Areas